Dr. Xu Wu, MD, PhD

Dr. Wu practices at St Mary Medical Center (PA) in Langhorne, Pennsylvania.

Dr. Wu's NPI, 1659631885, was assigned on May 22, 2012. Dr. Wu holds Pennsylvania license MD456446.

Dr. Wu's primary practice is St Mary Medical Center (PA), at 1201 Langhorne Newtown Rd, Langhorne, PA 19047 in Bucks County. The practice phone is (215) 710-2000.

Dr. Wu's primary practice is St Mary Medical Center (PA) in Langhorne, Pennsylvania. Dr. Wu is also affiliated with St. Mary Medical Center. The medical group on file is Trinity Health Mid-Atlantic Medical Group. Dmand AI also links Dr. Wu to 3 more hospitals and 12 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wu practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Wu's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Wu is licensed in Pennsylvania.

CMS data shows 714 Medicare services from Dr. Wu across 5 procedure codes in 2024, for 220 Medicare patients. Medicare paid $55,465 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 220 Medicare patients who saw Dr. Wu in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wu's median patient age at 72, with 49% women.

In 2024, Dr. Wu wrote 482 Medicare Part D claims for 224 patients. 85% of them were for generic drugs. CMS names the drug for 247 of them, across 13 drugs with 11 or more claims each, at $9,789 in total drug cost. In 2023, CMS named 169 claims across 9 drugs.

Dr. Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Dr. Wu, published from 2013 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Percutaneous Coronary Intervention, Antimalarials and Magnetic Resonance Imaging. Dr. Wu has published most often in BMJ Open. Dr. Wu's most frequent co-authors are Michelle Sang Hsiang, MD, Daniel E. Spratt, MD and Smita Das, MD, MPH, PhD.

CMS Open Payments shows 15 general payments to Dr. Wu from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $126.